Legora Raises $550 Million at $8.8 Billion, Priced Below Harvey on Revenue Multiple
Startups / analysis
Legora Raises $550 Million at $8.8 Billion, Priced Below Harvey on Revenue Multiple
The Stockholm legal-AI company doubled ARR to over $200 million in six months, and its round priced it at about 44 times that figure.
Legora announced a $550 million Series E on Wednesday, Oct. 21, at an $8.8 billion valuation, with Atreides Management leading, according to TechCrunch. The company's annual recurring revenue (ARR) is now above $200 million. That is a round that has been announced, and the sources do not say whether the money has been wired.
The valuation is the headline and the least informative number. Neither TechCrunch nor the Finwire wire item, carried by Placera, says whether $8.8 billion is pre-money or post-money. Until the company's own filing or release settles that, it is a single figure with an unstated base.
What $8.8 billion buys per dollar of revenue
TechCrunch reports ARR above $200 million, up from $100 million when Legora announced its previous round in April. Divide $8.8 billion by $200 million and the round prices Legora at no more than 44 times ARR, since "above $200 million" means the true multiple is a little lower.
The April round priced it at $5.6 billion against $100 million, or 56 times. So the valuation rose 57% in six months while revenue doubled, and the multiple fell by about a fifth. In plain terms, the new investors paid less per dollar of revenue than the April investors did.
That April round is described by TechCrunch as a $50 million extension of a $550 million Series D. The Series E is the same $550 million headline size, which makes the two easy to confuse in a table.
- Legora, April 2026 ($5.6B on $100M)56 x ARR
- Legora, October 2026 ($8.8B on $200M)44 x ARR
- Harvey, Sept. 2026 ($15.5B on March ARR of $200M)77.5 x ARR
Source: TechCrunch and Legal Business, accessed 2026-10-23; multiples calculated by The Terminal
Harvey sets the comparison
Harvey, Legora's closest rival, announced its own $550 million raise on Sept. 9 at a $15.5 billion valuation, led by Diffusion and Lightspeed Venture Partners, with Sapphire Ventures and Whale Rock also investing, per Legal Business. The same report says Harvey's valuation was $5 billion the previous summer.
The comparison is lopsided in one respect. TechCrunch says Harvey's ARR exceeded $200 million in March. Harvey has not been reported with a newer figure in either source, so the 77.5 times in the chart above is a ceiling built on a seven-month-old number. The real gap is probably narrower.
| Round | Valuation | Last ARR reported | |
|---|---|---|---|
| Legora | $550M Series E, Oct. 21 | $8.8B | Over $200M (October) |
| Harvey | $550M, Sept. 9 | $15.5B | Over $200M (March) |
The two companies have also moved at different speeds. Harvey's valuation went from $5 billion last summer to $15.5 billion, about a threefold rise in roughly a year, while Legora's rose from $5.6 billion to $8.8 billion, about 1.6 times, in six months. Legora is the smaller company, but its revenue growth over the same window is the better-documented of the two: Harvey's ARR figure is from March, and the sources reviewed carry no update. A reader comparing the two multiples is comparing a current number with a stale one, and the stale one favours Harvey's apparent price.
Who is paying, and for what
Finwire says the United States is now Legora's largest market by revenue. More than half of the 50 largest US law firms are customers, and in-house legal departments made up over 40% of new customers in the third quarter. Those are company figures relayed by a wire service, and neither source gives the denominator for the 40%.
The in-house number matters because law firms bill by the hour and have a structural reason to move slowly on tools that shrink billable time. A corporate legal department that buys directly faces no such conflict. Harvey's customer count, from Legal Business, is over 200,000 lawyers across nearly 2,500 organisations, including A&O Shearman, HSF Kramer, Reed Smith and Latham & Watkins. Legora has not published a comparable figure in the sources reviewed.
Finwire lists the participants beyond the lead as Baron Capital, Capital Group, Fidelity and J.P. Morgan, with existing backers Accel, Benchmark and Salesforce Ventures also taking part. TechCrunch's list differs: Baron Capital, Bessemer Venture Partners, General Catalyst and Menlo. The two lists overlap only on Baron, and neither claims to be complete. Which investors took how much, and what preference terms they hold, is not public.
What the round does not show
Two things would test the price. The first is net revenue retention, which neither source reports; ARR that doubles through new logos is cheaper to buy than ARR that doubles through expansion. The second is the spend: TechCrunch says the money goes to North American expansion, and Finwire adds international expansion and development of Legora's aOS platform. A company already earning most of its revenue in the US is buying a sales force for a market it has largely entered.
The same pattern of down-the-curve pricing showed up in a different shape in Warp Sciences' round, and the sale side of the market is covered in our look at boom-era startups sold below peak. Legora's next disclosed ARR figure, whenever it arrives, will show whether the 44 times was cheap.
Sources
More in Startups
- 01Tonbo Imaging Closes Debut 62% Above Issue Price, at About 128 Times Earnings, After a Sale of Existing Shares OnlyRevenue fell 22.7% in FY26 and the company took none of the ₹852 crore raised; the three cofounders sold ₹137.2 crore of stock.
- 02Garuda Aerospace Reports ₹206 Crore FY26 Revenue Ahead of a ₹1,000 Crore IPO, With Impairments Up 170-FoldThe Chennai drone maker's net profit rose about 41% to ₹25.9 crore while impairment losses jumped to ₹11.1 crore from ₹6.5 lakh.
- 03Alter, a YC S25 Startup, Launches Access Control for AI Agents With SOC 2 Still "In Progress"The Launch HN post promises to pass SOC 2, HIPAA and GDPR audits; the homepage lists SOC 2 as unfinished, in a market where rivals have raised $66 million and $120 million.
- 04Kevin Weil’s Warp Sciences Raises $215 Million at $865 Million, Above August TalksLightspeed led a round that came in 43 percent larger than the $150 million Business Insider reported in August, for robots that make and test drug candidates.